SCHEMBL19885437

SCHEMBL19885437

c1ccc2c(c1)Oc1ccccc1-c1cc(N(c3ccc(-c4ccc5oc6ccccc6c5c4)cc3)c3ccc(-c4ccc5oc6ccccc6c5c4)cc3)ccc1-2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.37
▸ NPC1 O15118 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ HSP90AA1 P07900 1/20 0.37
▸ HSP90AB1 P08238 1/20 0.37
▸ PLA2G2A P14555 5/20 0.36
▸ PLA2G4A P47712 5/20 0.36
▸ AHR P35869 2/20 0.34
▸ ALOX5 P09917 2/20 0.33
▸ CASP3 P42574 1/20 0.33
▸ SENP7 Q9BQF6 1/20 0.33
▸ SENP6 Q9GZR1 1/20 0.33
▸ TNKS O95271 1/20 0.33
▸ PLA2G10 O15496 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19885393 1.00 MAPT (0.37) MAPTNPC1MEN1KMT2ARAB9A
SCHEMBL19885410 0.99 MAPT (0.36) MAPTNPC1MEN1KMT2ARAB9A
SCHEMBL19885400 0.98 HSP90AA1 (0.35) MAPTNPC1MEN1KMT2ARAB9A
SCHEMBL19885419 0.98 HSP90AA1 (0.35) MAPTNPC1MEN1KMT2ARAB9A
SCHEMBL19888554 0.98 PLA2G2A (0.40) MAPTNPC1MEN1KMT2ARAB9A
SCHEMBL19885412 0.98 PLA2G2A (0.40) MAPTNPC1MEN1KMT2ARAB9A
SCHEMBL19885479 0.96 NPC1 (0.36) MAPTNPC1MEN1KMT2ARAB9A
SCHEMBL19885471 0.96 MAPT (0.36) MAPTNPC1MEN1KMT2ARAB9A
SCHEMBL19885484 0.96 NPC1 (0.38) MAPTNPC1MEN1KMT2ARAB9A
SCHEMBL19885473 0.94 MEN1 (0.35) MAPTNPC1MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10396292-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-08-27 — — US disclosed
US-20180053899-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-22 — — US disclosed
US-20180053899-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10396292-B2 Compound and organic electronic device using the same OR51E2, OR10J3, ESR1 MAPT 3328/4885NPC1 2043/4885MEN1 481/4885
US-20180053899-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME OR51E2, OR10J3, ESR1 MAPT 3328/4885NPC1 2043/4885MEN1 481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback